 |
|
|
| |
Week 72 Outcomes and COVID-19 Impact From the BRAAVE 2020 Study: A Randomized Switch to B/F/TAF in Black American Adults With HIV
|
| |
| |
IAS 2021 July 18-21
Princy Kumar,1 Jeffrey L. Stephens,2 Anson K. Wurapa,3 Indira Brar,4 Mary J. Burton,5 Shauna Applin,6 Aditya Gaur,7 Moti Ramgopal,8 Paul Benson,9 Christiana Blair,10 Kristen Andreatta,10 Hiba Graham,10 Sean E. Collins,10 Diana M. Brainard,10 Debbie Hagins,11 on behalf of the BRAAVE 2020 Investigators
1MedStar Health, Washington, DC, USA; 2Mercer School of Medicine, Macon, Georgia, USA; 3Infectious Disease Specialists of Atlanta, P.C., Decatur, Georgia, USA; 4Henry Ford Hospital, Detroit, Michigan, USA; 5G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi, USA; 6Hilltop Family Medical Clinic, Community Health Care, Tacoma, Washington, USA; 7St. Jude Children’s Research Hospital, Memphis, Tennessee, USA; 8Midway Research Center, Fort Pierce, Florida, USA; 9Be Well Medical, Berkley, Michigan, USA;10Gilead Sciences, Inc., Foster City, California, USA; 11The Chatham CARE Center, Chatham County Health Dept, Savannah, Georgia, USA
|
| |
|
|
|
|
|
